<DOC>
	<DOC>NCT00523783</DOC>
	<brief_summary>To assess the efficacy of 24-week treatment with quetiapine in patients with schizophrenia or schizoaffective disorder</brief_summary>
	<brief_title>Seroquel Long-Term NIS for Schizophrenia Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>The patient and the patient's legal representative (if any) must understand the nature of the study and must have given written consent The patient suffers from schizophrenia or schizoaffective disorder according to DSMIVTR The patient is between 18 and 65 years old(extremes included) On the basis of physical and neurological examination, medical history, the patient is, in the investigator's opinion, otherwise healthy If the subject is a female of childbearing potential, she must be not pregnant or breastfeeding and be using a reliable method of contraception. Reliable methods may include abstinence, hormonal contraceptives (eg,oral contraceptives or longterm injectable or implantable hormonal contraceptives), doublebarrier methods (eg, condom and diaphragm, condom and foam, condom and sponge), intrauterine devices, and tubal ligation The patients who have known hypersensitivity to quetiapine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective</keyword>
	<keyword>quetiapine</keyword>
	<keyword>long-term efficacy</keyword>
	<keyword>Naturalistic</keyword>
	<keyword>Observational</keyword>
</DOC>